 |
| Alpha Lipoic Acid |
Last updated: Sep 22, 2008 |
 |
|
 |
| |
Discovered in 1951, lipoic acid (also called alpha-lipoic acid or ALA) has long been recognized as a coenzyme that helps break down sugar for energy production during the Krebs cycle. Only recently has its therapeutic potential been realized.
Lipoic acid is medically approved in Germany for treating adult-onset type II diabetes and its complications. Ironically, the research that demonstrated its increased blood sugar utilization was done in the United States. Lipoic acid is not a controlling factor in such instances, but research shows that a high intake (300 to 600mg per day) tends to normalize blood sugar levels in diabetics. [Haugaard, N., et al. "Stimulation of glucose utilization by thioctic acid," Biophys Acta 222: 583-86, 1970]
Lipoic acid also fights free radical damage in both fatty and watery regions of cells and helps to recycle other antioxidants in what is described as "antioxidant synergism". A recent study showed that when lipoic acid was missing, other antioxidants did not interact well, thereby reducing their ability to protect cells. [Packer, L., et al. "Alpha-lipoic acid as a biological antioxidant," Free Radical Biol & Med. 19(2): 227-50, 1995]
It can be found in potatoes, carrots, broccoli, yeast, beets, yams and kohlrabi, and is also abundant in red meat. It is a vitamin-like antioxidant that is also produced naturally in the body; it is the only antioxidant that is fat- and water-soluble; it is easily absorbed and transported across cell membranes. Whereas many antioxidants only provide protection outside of cells, ALA is broken down inside cells to dihydrolipoic acid - an even more potent antioxidant. It also regenerates other antioxidants like vitamin C, vitamin E and glutathione.
It protects the liver from alcohol damage, the lungs from smoke damage, and enhances glucose disposal in type II diabetes and reduces associated neuropathy and cataracts. Individuals with capillary fragility (bruise easily) can benefit. While some human studies involve doses as high as 1,000mg daily, 100mg is sufficient to obtain the antioxidant effects in most cases.
Clinical applications for this nutrient include the following conditions: diabetic polyneuropathy, cataracts, glaucoma, ischemia-reperfusion injury, radiation injury, metal toxicity, Amanita mushroom poisoning and CCl4 poisoning. Because of its unique characteristics ALA is likely to have therapeutic application in a wide range of additional clinical conditions.
No RDA has been established. Humans are usually not deficient in alpha-lipoic acid, but supplementation can help in some conditions.
|
|
 |
|
 |
Alpha Lipoic Acid can help with the following: | |  | | | | Addictions | Alcohol-related Problems | Alpha-lipoic acid should not be given in high doses to patients suspected of having a thiamine deficiency unless the thiamine deficiency is also corrected. Individuals who may be deficient in vitamin B1 (such as alcoholics) should supplement vitamin B1 along with alpha-lipoic acid. |
| Aging |
Premature/Signs of Aging
Parkinson's Disease / Risk
Cataracts / Risk | It has been reported that lipoic acid has been shown to be helpful for cataracts. Some doctors caution that with a high body level for mercury, you risk moving mercury INTO the lens and brain rather than out, so lipoic acid should only be used if mercury levels are known to be low. |
| Autoimmune |
Diabetes Type I | There is considerable evidence that alpha lipoic acid can be used to prevent and treat diabetes, both type I (juvenile diabetes) and type II (mature onset diabetes) and the complications of diabetes. |
Multiple Sclerosis / Risk | Circulation |
Atherosclerosis | Recycles vitamins E and C when they've been used. Dosage: 50mg bid. |
Bruising Susceptibility
Increased Risk of Stroke | Environment / Toxicity |
Mercury Toxicity / Amalgam Illness | Sources of sulfur such as alpha lipoic acid, MSM and garlic are helpful for protection against heavy metals in general and specifically useful in mercury toxicity. Alpha lipoic acid should not be used alone, as it only mobilizes mercury with a weak bond. Without additional chelators present, such as DMPS or DMSA, the mercury may just redistribute elsewhere in the body instead of being removed. |
Heavy Metal Toxicity | Sources of sulfur such as alpha lipoic acid (ALA), MSM and garlic are helpful for protection against heavy metals in general and specifically useful in mercury toxicity. Alpha lipoic acid should not be used alone, as it only mobilizes mercury with a weak bond. Without additional chelators present, such as DMPS or DMSA, the mercury may just redistribute elsewhere in the body instead of being removed.
In animal studies, ALA has been found to protect from arsenic poisoning. [Arch Biochem Biophys 1960;86: pp.190-194 ] |
Cigarette Smoke Damage | Lab Values |
Low T-Helper Cell Level | Metabolic |
Metabolic Syndrome (Syndrome X) | Numerous additional studies have indicated that alpha lipoic acid (ALA) is useful for the treatment of diabetes mellitus which follows syndrome X. ALA stimulates increased glucose utilization in muscle cells and significantly reduces human insulin resistance. This process may occur via an insulin signaling pathway. |
| Nervous System |
Neuritis/Neuropathy | There was a marked synergy between GLA and alpha lipoic acid which produced compounds that had at least an order of magnitude increase in efficacy over either one alone in correcting motor nerve conduction velocity and endoneural blood flow defects. A 1.3:1 GLA:alpha lipoic acid ratio appears to be optimal against experimental diabetic neuropathy. [Diabetologia (1998), 41: pp.390-399 (rat study)]
Experimental work confirms that GLA-aLA (equimolar) conjugate is so effective that it completely reverses the effects of the broken neurotrophic mechanisms that correlate with diabetic neuropathy. [Diabetologia 1998 Jul; 41(7): pp.839-843] |
| Nutrients |
Antioxidant Requirement / Oxidative Stress | Organ Health |
Diabetes Type II / Risk | Numerous additional studies have indicated that ALA is useful for the treatment of diabetes mellitus. It stimulates increased glucose utilization in muscle cells and significantly reduces human insulin resistance.
600mg of alpha lipoic acid tid was found to improve polyneuropathy symptoms in patients with type II diabetes. A maintenance dose as low as 100mg tid may be sufficient to provide benefits. [Diabet Med 1999;16; pp.1040-1043] |
Liver Detoxification / Support Requirement | Alpha-lipoic acid has been used very successfully as a therapeutic agent in a number of conditions relating to liver disease, including alcohol-induced damage, mushroom poisoning, metal intoxification and carbon tetrachloride poisoning. |
Hepatitis | Alpha lipoic acid is given in a dose of 300mg at least twice per day for hepatitis B or C. Alpha lipoic acid (ALA), silymarin, and selenium have been used in combination with success in reducing symptoms and elevated liver enzyme levels (though the viral load was not substantially reduced). |
Glaucoma | 150mg per day improves visual function in people with both stage I and stage II glaucoma. [Vestn Oftalmol 1995;111: pp.6-8] |
| Risks |
Increased Risk of Pancreatic Cancer | Please see the link between Increased Risk of Pancreatic Cancer and LDN. The dose of Alpha Lipoic Acid used with the patient to increase his survival time was 300 to 600 mg intravenously twice weekly and orally, ALA 300 mg twice daily. |
| Tumors, Malignant |
Pancreatic Cancer | Please see the link between Pancreatic Cancer and LDN. The dose of Alpha Lipoic Acid used with the patient to increase his survival time was 300 to 600 mg intravenously twice weekly and orally, ALA 300 mg twice daily. |
|
| |  | |  |
KEY |  | May do some good |  |  | Likely to help |  |  | Highly recommended |
|
 |